Vorapaxar in Patients with Peripheral Artery Disease with or without Previous Limb Revascularization

被引：0
|
作者：
Bonaca, Marc P. [1 ]
Creager, Mark A. [1 ]
Scirica, Benjamin S. [1 ]
Murphy, Sabina A. [1 ]
Braunwald, Eugene [1 ]
Morrow, David A. [1 ]
机构：
[1] Brigham & Womens Hosp, Boston, MA 02115 USA
来源：
VASCULAR MEDICINE | 2015年 / 20卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R6 [外科学];
学科分类号：
1002 ; 100210 ;
摘要：
Poster 16
引用
收藏
页码：286 / 287
页数：2
相关论文
共 50 条
  • [1] Appropriate Use of Vorapaxar in Patients With Peripheral Artery Disease
    Safian, Robert D.
    JACC-CARDIOVASCULAR INTERVENTIONS, 2016, 9 (20) : 2165 - 2166
  • [2] Vorapaxar for Prevention of Major Adverse Cardiovascular and Limb Events in Peripheral Artery Disease
    Morrison, Justin T.
    Govsyeyev, Nicholas
    Hess, Connie N.
    Bonaca, Marc P.
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY AND THERAPEUTICS, 2022, 27
  • [3] Peripheral Revascularization in Patients With Peripheral Artery Disease With Vorapaxar Insights From the TRA 2°P-TIMI 50 Trial
    Bonaca, Marc P.
    Creager, Mark A.
    Olin, Jeffrey
    Scirica, Benjamin M.
    Gilchrist, Ian C., Jr.
    Murphy, Sabina A.
    Goodrich, Erica L.
    Braunwald, Eugene
    Morrow, David A.
    JACC-CARDIOVASCULAR INTERVENTIONS, 2016, 9 (20) : 2157 - 2164
  • [4] RISK AND COSTS AFTER PERIPHERAL REVASCULARIZATION IN PATIENTS WITH PERIPHERAL ARTERY DISEASE WITH AND WITHOUT DIABETES
    Hess, Connie Ng
    Fu, Julia Weleski
    Gundrum, Jacob
    LaPointe, Nancy Allen
    Wang, Tracy
    Rogers, Kevin
    Hiatt, William R.
    Bonaca, Marc P.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2020, 75 (11) : 1303 - 1303
  • [5] Effect of vorapaxar on cardiovascular and limb outcomes in patients with peripheral artery disease with and without coronary artery disease: Analysis from the TRA 2°P-TIMI 50 trial
    Qamar, Arman
    Morrow, David A.
    Creager, Mark A.
    Scirica, Benjamin M.
    Olin, Jeffrey W.
    Beckman, Joshua A.
    Murphy, Sabina A.
    Bonaca, Marc P.
    VASCULAR MEDICINE, 2020, 25 (02) : 124 - 132
  • [6] Vorapaxar prevents progression of peripheral artery disease
    William R. Hiatt
    Nature Reviews Cardiology, 2013, 10 : 367 - 368
  • [7] LESION LOCALIZATION AND LIMB OUTCOMES IN PATIENTS WITH AND WITHOUT DIABETES WHO UNDERGO ENDOVASCULAR REVASCULARIZATION DUE TO SYMPTOMATIC PERIPHERAL ARTERY DISEASE
    Katsiki, Niki
    Rammos, Christos
    Schoefthaler, Christoph
    Korosoglou, Grigorios
    ATHEROSCLEROSIS, 2024, 395
  • [8] Peripheral artery disease, lower limb revascularization, and amputation in diabetes patients with and without coronary artery disease: a cohort study from the Western Denmark Heart Registry
    Olesen, Kevin Kris Warnakula
    Gyldenkerne, Christine
    Thim, Troels
    Thomsen, Reimar Wernich
    Maeng, Michael
    BMJ OPEN DIABETES RESEARCH & CARE, 2021, 9 (01)
  • [9] Association of Ankle-Brachial Indices With Limb Revascularization or Amputation in Patients With Peripheral Artery Disease
    Pacha, Homam Moussa
    Mallipeddi, Vishnu P.
    Afzal, Naveed
    Moon, Sungrim
    Kaggal, Vinod C.
    Kaira, Manju
    Oderich, Gustavo S.
    Wennberg, Paul W.
    Rooke, Thorn W.
    Scott, Christopher G.
    Kullo, Iftikhar J.
    McBane, Robert D., II
    Nishimura, Rick A.
    Chaudhry, Rajeev
    Liu, Hongfang
    Arruda-Olson, Adelaide M.
    JAMA NETWORK OPEN, 2018, 1 (08) : e185547
  • [10] Comparative effectiveness of endovascular and surgical revascularization for patients with peripheral artery disease and critical limb ischemia: Systematic review of revascularization in critical limb ischemia
    Jones, W. Schuyler
    Dolor, Rowena J.
    Hasselblad, Vic
    Vemulapalli, Sreekanth
    Subherwal, Sumeet
    Schmit, Kristine
    Heidenfelder, Brooke
    Patel, Manesh R.
    AMERICAN HEART JOURNAL, 2014, 167 (04) : 489 - U112
12345